We therefore searched our in-house endometrial cancer data set (Cheung et al., 2011) and The Cancer Genome Atlas (TCGA) (Figure 5—figure supplement 1) (Cerami et al., 2012) for cancer patient-derived PIK3R1 mutations that could target p85α homodimerization. This evidence concerns the gene PIK3R1 and cancer.